Raymond P Donnelly
Overview
Explore the profile of Raymond P Donnelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
3869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donnelly R
J Interferon Cytokine Res
. 2025 Jan;
45(2):39-42.
PMID: 39866122
The suppressors of cytokine signaling (SOCS) genes were first described in a group of articles published in 1997. Since that time, much has been learned about the functional activities mediated...
2.
Kulka M, Keinard B, Sosnovtsev S, Ilyushina N, Donnelly R, Dickensheets H, et al.
J Virol Methods
. 2024 Dec;
333:115104.
PMID: 39724953
Human norovirus (HuNoV) and human astrovirus (HAstV) are viral enteric pathogens and known causative agents of acute gastroenteritis. Identifying the presence of these viruses in environmental samples such as irrigation...
3.
Donnelly R, Prokunina-Olsson L
J Interferon Cytokine Res
. 2023 Sep;
43(9):359-362.
PMID: 37725009
It has now been 20 years since the original discovery of the interferon λ (IFN-λ) family (Kotenko et al., 2003; Sheppard et al., 2003) and 10 years since the subsequent...
4.
de Weerd N, Ogungbola O, Liu X, Matthews A, Ismail A, Vivian J, et al.
J Interferon Cytokine Res
. 2023 Jul;
43(9):403-413.
PMID: 37499093
Type III interferons (IFN-lambdas, IFN-λs) are important antiviral cytokines that can also modulate immune responses by acting through a heterodimeric receptor composed of the specific and limited expressed IFN-λR1 chain...
5.
Hickerson B, Petrovskaya S, Dickensheets H, Donnelly R, Ince W, Ilyushina N
J Virol
. 2023 Jul;
97(7):e0015423.
PMID: 37404185
Baloxavir marboxil (baloxavir) is a recently FDA-approved influenza virus polymerase acidic (PA) endonuclease inhibitor. Several PA substitutions have been demonstrated to confer reduced susceptibility to baloxavir; however, their impacts on...
6.
Donnelly R
J Interferon Cytokine Res
. 2023 Mar;
43(3):105-107.
PMID: 36939811
No abstract available.
7.
8.
Hickerson B, Sheikh F, Donnelly R, Ilyushina N
J Interferon Cytokine Res
. 2023 Jan;
43(1):35-42.
PMID: 36651846
The human beta-coronavirus strain, OC43, provides a useful model for testing the antiviral activity of various agents. We compared the activity of several antiviral drugs against OC43, including remdesivir, chloroquine,...
9.
Endo Y, Hickerson B, Ilyushina N, Mohan N, Peng H, Takeda K, et al.
J Virus Erad
. 2022 Dec;
8(4):100307.
PMID: 36514715
Because of rapid emergence and circulation of the SARS-CoV-2 variants, especially Omicron which shows increased transmissibility and resistant to antibodies, there is an urgent need to develop novel therapeutic drugs...
10.
Hickerson B, Adams S, Bovin N, Donnelly R, Ilyushina N
Acta Virol
. 2022 Aug;
66(3):263-274.
PMID: 36029091
Interferons (IFNs) mediate innate antiviral activity against many types of viruses, including influenza viruses. In light of their potential use as anti-influenza agents, we examined whether resistance to these host...